These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18718065)

  • 1. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway].
    Xiao H; Zhang KJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):804-8. PubMed ID: 18718065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
    Xiao H; Xiao Q; Zhang K; Zuo X; Shrestha UK
    Ann Hematol; 2010 Apr; 89(4):399-404. PubMed ID: 19756599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal of multidrug resistance of the drug resistant human multiple myeloma cell line MOLP-2/R by curcumin and its relation with FA/BRCA pathway].
    Xiao H; Zhang KJ; Zuo XL
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):33-7. PubMed ID: 19563033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R.
    Xiong T; Wei H; Chen X; Xiao H
    Int J Oncol; 2015 Jan; 46(1):223-32. PubMed ID: 25351371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of PARP1 inhibitor PJ34 on multi-drug resistance in human multiple myeloma cell line and its relationship with FA/BRCA pathway].
    Xiong T; Wei H; Chen X; Xiao H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):312-6. PubMed ID: 24928009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
    Peremartí J; Ramos F; Marcos R; Hernández A
    Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen F
    Leuk Lymphoma; 2015 Mar; 56(3):755-62. PubMed ID: 24996439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.
    Dai CH; Li J; Chen P; Jiang HG; Wu M; Chen YC
    J Biomed Sci; 2015 Sep; 22(1):77. PubMed ID: 26385482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP
    Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
    Snyder ER; Ricker JL; Chen Z; Waes CV
    Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
    Dunn J; Potter M; Rees A; Rünger TM
    Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin.
    Burkitt K; Ljungman M
    Mol Cancer; 2008 Mar; 7():24. PubMed ID: 18325101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversing effects of curcumin on multi-drug resistance of Bel7402/5-fu cell line].
    Cao SQ; Yin TY; Yang SL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):244-7, 252. PubMed ID: 22574602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29.
    Du B; Jiang L; Xia Q; Zhong L
    Chemotherapy; 2006; 52(1):23-8. PubMed ID: 16340194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects of FA/BRCA pathway in lymphoma cell lines.
    Xiao H; Zhang KJ; Xia B
    Int J Hematol; 2008 Dec; 88(5):543-550. PubMed ID: 19011769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation.
    Liu Q; Ghosh P; Magpayo N; Testa M; Tang S; Gheorghiu L; Biggs P; Paganetti H; Efstathiou JA; Lu HM; Held KD; Willers H
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1081-9. PubMed ID: 25832698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
    Wu M; Yuan Y; Pan YY; Zhang Y
    Mol Med Rep; 2014 Aug; 10(2):931-8. PubMed ID: 24840891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.